AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, 2025, the company recorded revenues of RMB 1,285 million in 2024, an ...

Hepatitis can damage your liver for years without symptoms. Learn how these viruses spread—and what truly protects your liver ...

Victims of infected blood are dying "two a week" while awaiting compensation for the biggest scandal in the history of the ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

Arbutus Biopharma restructures to cut costs & focus on Hepatitis B drug imdusiran. Read more about ABUS stock here.

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...

Arbutus is also exiting its corporate headquarters in Pennsylvania and will terminate all in-house scientific research. The ...

Operator: Greetings, and welcome to the DURECT Corporation Fourth Quarter and Full Year 2024 Earnings Conference Call. At ...

Without adequate resources, an estimated 12.8 million displaced people, including 6.3 million children, could be left without life-saving health interventions in 2025, UNHCR, the UN Refugee Agency ...

The hepatitis A virus (HAV) is one of the main causes of viral hepatitis and is responsible for an estimated 159,000 ...

"An adversarial collaboration on vaccines could serve as a model," write Drs. Christopher M. Worsham and Anupam B. Jena.

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Gilead Sciences ...